The HER2+ Breast Cancer market was impacted by data presented during the San Antonio Breast Cancer Symposium (SABCS) meeting in San Antonio, TX.

Breaking Data worked with 30 oncologists during the meeting to better understand the commercial implications of data presented.

Companies presenting data include: Genentech, Puma, Seattle Genetics, AstraZeneca

Get immediate access to this 60-slide report so you can make better decisions today and prepare for tomorrow.

HER2+ BREAST CANCER REPORT SABCS 2019

San Antonio, TX
Dec 10 to Dec 14

Share: